This post has been de-listed
It is no longer included in search results and normal feeds (front page, hot posts, subreddit posts, etc). It remains visible only via the author's post history.
Looking for a high end forecast to see what the ceiling is on this thing. With four seperate ph2 trials and other potential revenue from ownership of that CAR-T Bio company, what do you all think the potential market cap would be? Is this potentially a 10b MCAP company? That would imply a 100x upside on share price, seems unlikely...maybe 5b is more reasonable? Still a 50x gain
Really difficult to come up with a “maximum,” since if Karisma is successful, we could have the first breast cancer preventative pill on the market. Like Quay says, how many women get mammograms each year? That could produce revenue in the billions annually.
And if Evangeline is successful, Endoxifen could replace Tamoxifen (another 700M/annually).
So 5B-10B (or $40-$80 per share) seems like a reasonable range if both these trials are successful.
Subreddit
Post Details
- Posted
- 10 months ago
- Reddit URL
- View post on reddit.com
- External URL
- reddit.com/r/AtossaThera...